Adam R. Craig serves as Executive at Innovive Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Adam R. Craig has executed 56 insider transactions totaling $5.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 1, 2020 involved receiving (via award) 5,000 shares valued at $4.9K.
Adam R. Craig currently holds 376,087 shares of Innovive Pharmaceuticals, Inc. (IVPH.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam R. Craig has been a net seller of IVPH.OB stock. They have purchased $282.8K and sold $5.1M worth of shares.
Adam R. Craig's most recent insider trade was on Jul 1, 2020, when they sold 5,000 shares at $0.98 per share.
Get notified when new Form 4 filings are submitted
| $2.22 |
| Discretionary |
| Feb 27, 2015 | SNSS | $0 | Award | 19,031 | $N/A | Discretionary |
| Aug 27, 2014 | SNSS | $20.4K | Sale | 2,554 | $8.00 | Discretionary |
| Feb 28, 2013 | SNSS | $0 | Award | 7,662 | $N/A | Discretionary |
| Aug 10, 2006 | IVPH.OB | $67.8K | Conversion | 17,120 | $3.96 | Discretionary |